Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $185.74M-28.3% | $259.19M-10.3% | $288.95M-67.3% | $883M+10.5% | ||
| $151.75M+0.6% | $150.88M+1.4% | $148.74M-12.0% | $168.96M+20.2% | ||
| $33.99M-68.6% | $108.31M-22.7% | $140.2M-80.4% | $714.04M+8.4% | ||
| 18.3%-23.5pp | 41.8%-6.7pp | 48.5%-32.3pp | 80.9%-1.5pp | ||
| $17.4M-9.5% | $19.22M+11.2% | $17.28M-5.9% | $18.37M+20.7% | ||
| $145.12M-10.3% | $161.77M+6.9% | $151.39M+17.1% | $129.26M+29.2% | ||
| $288.89M-31.4% | $420.84M— | —— | $308.79M+26.2% | ||
| -$215.27M+8.6% | -$235.62M-644% | -$31.65M-106% | $574.22M+3.5% | ||
| -115.9%-25.0pp | -90.9%-80.0pp | -11%-76.0pp | 65%-4.4pp | ||
| $26.99M-43.4% | $47.7M+3.9% | $45.89M+125% | $20.41M-32.5% | ||
| -$4.15M-74.2% | -$2.38M-72.0% | -$1.39M— | —— | ||
| -$234.97M+10.1% | -$261.48M-142% | $617.74M+12.0% | $551.47M+3.9% | ||
| -$4.22M-127% | -$1.86M-100% | $756.11M+1,143% | $60.81M-1.1% | ||
| -$130.77M+9.7% | -$144.85M-21.7% | -$119.03M-154% | $220.21M+21.0% | ||
| -70.4%-14.5pp | -55.9%-14.7pp | -41.2%-66.1pp | 24.9%+2.2pp | ||
| -$0.90+11.8% | -$1.02-13.3% | -$0.90-154% | $1.67+7.7% | ||
| -$163.76M+12.5% | -$187.23M-2,276% | $8.61M-98.6% | $606.05M+4.6% | ||
| -88.2%-15.9pp | -72.2%-75.2pp | 3%-65.7pp | 68.6%-3.9pp | ||
| -$215.27M+8.6% | -$235.62M-644% | -$31.65M-106% | $574.22M+3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $204.7M in revenue over the trailing twelve months, down 15.3% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $104.6M over the trailing twelve months, a -51.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 29.3% and operating margin is -82.2%, with a -51.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.71.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
